Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses
Shuni Duan(Beijing University of Chinese Medicine), Runping Liu(Beijing University of Chinese Medicine)
Cited by 14
Related Papers
LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles
|Acta Pharmacologica Sinica|2023|33